chrisvoncsefalvay/vaers-outcomes huggingface dataset:
feeling dizzy; Fever; sore arm; This is a spontaneous report from a contactable consumer or other non hcp (Patient).  A 62-years-old non pregnant female patient received first dose of bnt162b2 (BNT162B2, PFIZER-BIOTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: ER8732), via an unspecified route of administration, administered in Arm Left on 26Mar2021 11:30 (Age at vaccination: 62-years-old) as single dose for covid-19 immunization. Medical history included Esophagitus, allergies to Percocet, Bactrim, Seasonal allergies all from an unknown date and unknown if ongoing. Patient was not diagnosed with covid prior to vaccination. patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. patient did not receive any other medications within 2 weeks of vaccination. The patient concomitant medications were not reported. It was reported that on 26Mar2021 14:00 patient experienced Fever sore arm and feeling dizzy. Patient did not receive any treatment for the events. Patient was not hospitalized for the events. Patient was not tested covid post vaccination. patient underwent lab tests and procedures which included body temperature: fever on 26Mar2021. The outcome for the events was reported as unknown at the time of this report.  Information on Lot/Batch number was available. No further information is expected.
At 2 PM Friday, March 12, patient was cleaning house and began speaking incoherently. Due to the aphasia, her daughter called 911. The ambulance delivered her to Hospital by 2:20. She presented with a brain hemoragh. Hospital called for medivac which took her to another Hospital.  The bleeding continued and the docs ruled out surgery.  They were unable to slow the bleed. Patient was put on a ventilor shortly after arriving at hospital. Patient passed at 6:55 PM March 13.
Hacking cough; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Hacking cough) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025B21A and 011A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In April 2021, the patient experienced COUGH (Hacking cough). At the time of the report, COUGH (Hacking cough) had not resolved.            No relevant concomitant medications were reported.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 20-Aug-2021: Non-Significant Follow-up received on 20-AUG-2021: No new information received.
Started with itching, pain. arm is now red, swollen, warm to touch. Dexamethasone 10mg/ml given in office. Script for methylprednisolone 4mg pack sent to pharmacy.
Associate experienced sharp pain, redness, swelling, itching,  burning, stiff neck. 1/27 and 1/28 she took Benedryl and Motrin over the counter for her symptoms. Presented to associate health 1/30/2023 and was sent to Solutions for assessment by a provider.
pt recv vax 21MAY97 & pt devel a round red rash w/a rim around it on both forearms;pt devel 20-25 lesions total;
The day after I was really fatigued , headaches, dizzy, neck pain, left shoulder pain and pain in my left arm. I felt cold and chills and this lasted for a few days. I felt like myself starting Sunday but I have still have intermitted headaches and dizziness. The headaches and dizziness is still present and it has been a week since my injection.
This spontaneous report as received from a registered nurse refers to two patients of unknown age. On an unknown date, the two patients were vaccinated with PNEUMOVAX 23 (lot # H017759) at different unspecified time. The dose, frequency and route of PNEUMOVAX 23 was not specified. At an unspecified time after administered PNEUMOVAX 23, one patient experienced cellulitis and fever, and the other patient just started to develop symptoms similar to the patient just mentioned. The outcome of the patient with cellulitis and fever was unknown; the outcome of the other patient was unknown. The primary reporter required a lot check. No PQC reported. Follow-up information has been requested from a healthcare worker concerning three (previously reported two) unspecified patients vaccinated with PNEUMOVAX 23 on an unspecified date. The patients experienced cellulitis and fever on an unknown date. The healthcare worker did not have any details of the particular adverse effect occurred. There were no patient contact details available. Follow-up information has been received from a registered nurse stated that this report pertains to two patients not three and that one of the two patients was a male patient who was "unable to drive home from down south and had to fly home because of this issue". This is one of two reports from the same source. Additional information has been requested.
Patient presented to the ED on 8/30/2021 with shortness of breath and low O2. Patient reports that she was vaccinated with Moderna for COVID x 2 (last dose March 2021). She went to the beach with family, including her daughter who had cold like symptoms. Patient subsequently tested positive for COVID on 8/21/21 along with the rest of her family. She spoke to her PCP today as it has been 10 days since diagnosis and she is still not feeling back to normal. She obtained a pulse oximeter and pulse ox went down to as low as 85% so presented to the ED.
Information has been received from a health professional, a nurse, concerning a 79 yr old female who on 23Nov04 was vaccinated with pneumococcal 23v polysaccharide vaccine (lot 649988/0692P). On 24Nov04 the pt experienced super swollen site reaction that was red and pink down to the elbow. Also reported that two other pt's (WAES No 0411USA04074 and 0411USA03975) experienced the same super swollen site reaction that were red and pink down to the elbow onset date was 23Nov04 and 22Nov04. No further information is available.
Patient fainted approximately 5 minutes after vaccination. She came too right away. Patient was hot and shaky, was given apple juice to drink. Patient started to feel better and advised to wait longer for observation. After approximately another 5 minutes,patient fainted again. Pharmacist went to patient. Patient remained unconsicous this time with labored breathing so 911 was called and EMS arrived. Laid patient out with legs raised and put ice to cool patient on her head while awaiting EMS. Patient regained consciousness and breathing returned to normal. Ems evaluated patient, blood pressure normal and oxygen levels normal. EMS let patient go home with her partner with instructions to go to ER if a 3rd fainting episode occured.
Information has been received from a pharmacist concerning a 50 year old male patient. The patient's concurrent condition, concomitant therapy and medical history and were not provided. On 04-APR-2017, the patient was vaccinated with a dose of ZOSTAVAX (lot # M038864, expiration date: 12-DEC-2017, dose was unknown, subcutaneous) for "shingles" (Product use in unapproved indication). On 06-APR-2017, the patient experienced "symptoms". No treatment was given for the event. The pharmacist could not provide the lot and expiration for the properly stored sterile diluent (manufacturer unknown) used to reconstitute the dose of ZOSTAVAX. At time of the report, the outcome of the event "symptoms" was reported as not recovered. Causality between "symptoms" and ZOSTAVAX and sterile diluent (manufacturer unknown) was not provided. Additional information has been requested.
Information has been received from a mother concerning her son with seasonal allergies and no other pertinent medical history who vaccinated with a dose of mumps virus vaccine. Five days after vaccination, the patient experienced pneumonia. No product quality complaint was involved. The mother also reported that her son received a dose of rubella virus vaccine and developed transient disorder, sleep deprivation, and movement disorder (WAES 0806USA03295). Additional information has been requested.
When moves arm in upward motion has pain. Can not pick heavier objects with out experiencing a sharp pain. Hurts when received vaccine then passed two days later pain in arm started.
pt recvd vax;14 days later, devel wheezing & hives;am of rxn,pt had eggs & since then another occurence of wheezing & hives in assoc w/ eating eggs;prior to MMR,ate eggs w/out experience allergic sxs;
very sharp pains in chest and going up into their throat; very sharp pains in chest and going up into their throat; Pulse went up to 101; fever; chills; Arm is extremely sore; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Arm is extremely sore), CHEST PAIN (very sharp pains in chest and going up into their throat), PYREXIA (fever), CHILLS (chills) and OROPHARYNGEAL PAIN (very sharp pains in chest and going up into their throat) in a 69-year-old female patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     The patient had no known allergies, no previous health conditions and no previous heart or blood pressure concerns. It was unknown whether the patient had received any other vaccines in the 4 weeks prior to COVID-19 vaccine.  Previously administered products included for Product used for unknown indication: Pfizer (dose 1), Pfizer (dose 3) and Pfizer (dose 2). Past adverse reactions to the above products included No adverse event with Pfizer, Pfizer and Pfizer.    On 18-Sep-2023, the patient received fourth dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On 18-Sep-2023, the patient experienced PAIN IN EXTREMITY (Arm is extremely sore), PYREXIA (fever), CHILLS (chills) and PULSE ABNORMAL (Pulse went up to 101). On 20-Sep-2023, the patient experienced CHEST PAIN (very sharp pains in chest and going up into their throat) and OROPHARYNGEAL PAIN (very sharp pains in chest and going up into their throat). The patient was treated with ACETAMINOPHEN on 19-Sep-2023 at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Arm is extremely sore), CHEST PAIN (very sharp pains in chest and going up into their throat), PYREXIA (fever), CHILLS (chills), OROPHARYNGEAL PAIN (very sharp pains in chest and going up into their throat) and PULSE ABNORMAL (Pulse went up to 101) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Sep-2023, Blood pressure measurement: normal. On 18-Sep-2023, Body temperature: temperature went up to 101 degrees.    At night, temperature went from 101.7 to 102. On 18-Sep-2023, Heart rate: 100 and Pulse went up to 101.         No concomitant medication was reported. The patient had received the most recent Moderna Spikevax vaccine a couple of days ago. It didn't happen immediate but later in the day temperature went up to 101 degrees which isn't super serious. The pulse went up to 101 and it was normally above 60. The patient was left-handed and was given the shot in left arm. Arm was extremely sore. Two days later on 20th Sep, the patient got a very sharp pains in chest and going up into the throat. The patient's arm was sore right after the shot on 18th Sep, but as the day went on the arm pain got worse and worse and then got fever and chills. This was at night, late evening. The patient took temperature, it was 101.7 to 102. The heart rate was about 100 and blood pressure was normal.
No additional AE reported; HCP reporting VAQTA, PEDVAXHIB, and ROTATEQ were administered after a temperature excursion. Caller stated she did not have the exact dates of administration nor the names of the patients involved. No additional information provided. No additional AE; This spontaneous report was received from a Health Care Professional and refers to a 15-month-old male patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.  On 14-DEC-2022, the patient was vaccinated with the third dose of Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAXHIB) intramuscular injection, in right thigh, lot #W023937, expiration date: 06-DEC-2023, administered intramuscularly for prophylaxis (strength was not provided).  The administered dose of the vaccine experienced a temperature excursion (product storage error) since 01-DEC-2022. The vaccine administered were stored at temperatures excursion of 47.9 Fahrenheit (storage in clinical practice) for 47 minutes . Data logger was involved.  No adverse event was reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2301USA001175: US-009507513-2301USA009088: US-009507513-2301USA009024: US-009507513-2301USA009110: US-009507513-2301USA009878: US-009507513-2301USA009943: US-009507513-2301USA009933:
THE PUNCTURED VIAL STORED IN THE REFRIGERATOR FOR 7 HOURS PRIOR TO ADMINISTRATION; INCORRECTLY STORED VACCINE ADMINISTERED/ DOSE OF VACCINE 1 HOUR PAST ITS  BEYOND USE TIME; This spontaneous report received from a health care professional concerned a 57 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 211D21A, and expiry: 11-APR-2022) dose was not reported, administered on 29-NOV-2021 for prophylactic vaccination. No concomitant medications were reported. On 29-NOV-2021, the patient experienced the punctured vial stored in the refrigerator for 7 hours prior to administration. On 29-NOV-2021, the patient experienced incorrectly stored vaccine administered/ dose of vaccine 1 hour past its beyond use time. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the the punctured vial stored in the refrigerator for 7 hours prior to administration and incorrectly stored vaccine administered/ dose of vaccine 1 hour past its beyond use time was not reported. This report was non-serious.
Symptoms began 24 hours after second dose of vaccine - chills, body aches, large, swollen, hard lump at injection site - increased to about 4 inches across - very painful arm, stomach upset - diarrhea, extreme fatigue, dizziness /brain fog. The symptoms lasted from one day after injection (Friday evening) until the following Tuesday morning.
Headache, Nausea, Swollen Arm, Shoulder blade. Swollen Lymph nodes Left Arm where vaccination was administered. Severe tenderness, reduced arm mobility Localized Arthus reaction, pain, swelling, edema. Treatment-7 day course of steroid 20mg. Day 8, Problem is 90% resolved.
Information has been received from a nurse practitioner concerning a female who on an unspecified date was vaccinated subcutaneously with a 0.65 dose of ZOSTAVAX vaccine (Oka/Merck) (lot no. and site of injection were not reported). The reporter reported that she heard the patient of their clinic, developed a mild rash, shortly after being vaccinated with ZOSTAVAX vaccine (Oka/Merck). The patient did not seek medical attention. Additional information has been requested.
No adverse effects reported; the patient received her first dose of Gardasi 3 years ago; This spontaneous report was received from a pharmacist and refers to a female patient of unknown age. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On an unknown date in 2016, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, 1 dose for prophylaxis (route of administration, injection site, lot # and expiration date were not reported). On 09-AUG-2019, the patient visited the office to receive the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9), injection, 1 dose for prophylaxis, lot# N017832, expiration date: 16-NOV-2016 (route of administration and injection site were not reported). No adverse effects were reported.
Swollen and sore right upper arm, with pain running up neck and into head for 3 days after injection
GAVE 2ND BOOSTER OF PFIZER VACCINE; NO SIDE EFFECT
A  state of calm euphoria, roughly comparable to having a raised level of Serotonin. Felt wonderful and relaxful.; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Evel82) via an unspecified route of administration in the left arm on 12May2021 at 18:30 (at the age of 55-year-old) as a single dose for COVID-19 immunisation. Medical history and known allergies were reported as NA. The patient did not take any concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 12May2021 at 20:30, the patient experienced ''a state of calm euphoria, roughly comparable to having a raised level of serotonin felt wonderful and relaxful.'' This was an unusual reaction so patient wanted to note this formally. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as result of these events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event '' a state of calm euphoria, roughly comparable to having a raised level of serotonin felt wonderful and relaxful'' was recovered with sequelae on an unknown date in May2021.  No follow-up attempts are needed. No further information is expected.
Immediately after flu shot , felt lightheaded then headache and nauseous Headache and nausea persisted for about 4 hrs until had felt good and next.
The night of the second injection I had fever, chills, headache, and a sleepless night.  Just over two weeks later, I had rapid heart rate, arrhythmia, and feeling of inflammation and discomfort in my chest which lasted until late July.
Hip and back joint pain, fever, chills, headache, heart palpitations, intermittent chest pain
Per Dr. discharge summary: "Patient is a 76 Y male with DM, HTN, CAD, CVA, recent hospitalization 12/29-1/6 for R foot ischemia/ulcer s/p R femoral endarterectomy/angioplatsy, s/p TMA, discharged to SNF, here for R foot infection. - S/p AKA 1/22/23.  abx stopped 1/25/23. Tolerated well. Pain controlled. Afebrile, HDS, VSS. Will need SNF to recover"   I assumed care of the patient on 1/30/23 at which time he was medically ready for discharge and remains in the hospital while awaiting bed at care center.
Initial misuse report received from a healthcare professional on August 2013. It was reported that whole vaccination the patient (No information was provided regarding the patient) moved and full amount of DAPTACEL vaccine could not be administered. No adverse event was reported. List of documents held by sender: none.
On 9/3/99, post vax, the pt experienced diarrhea, fever of 101-102F and red spots on the face. At the time of the report, the pt's symptoms were resolving and the red spots on her face had scabbed over. No further information is available.
MS related symptoms; Shortness of breath; Headache; Fever; A spontaneous report was received from a consumer, concerning his wife, a female patient of unspecified age, who received Moderna's COVID-19 vaccine and experienced MS related symptoms/multiple sclerosis), shortness of breath, headache and fever/pyrexia.  The patient's medical history was not provided. Concomitant product use was not provided by the reporter.     On 03 Feb 2021, prior to the onset of the symptoms, the patient received his first of two planned doses of mRNA-1273 (Batch number not provided) via unknown route for prophylaxis of COVID-19 infection.   On an unspecified date in Feb 2021, after vaccine administration in afternoon, the patient started to experience shortness of breath, headache, fever, and MS related symptoms and these side effects were currently ongoing. No treatment medications were reported.    Action taken with mRNA-1273 in response to the events were not provided.  The outcome of the events, MS related symptoms, shortness of breath, headache and fever were considered not resolved at the time of this report.; Reporter's Comments: Very limited information regarding the events has been provided at this time.  Additional information has been requested.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded
12 or 13 expired booster doses were administered past manufacturer expiration; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (12 or 13 expired booster doses were administered past manufacturer expiration) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (12 or 13 expired booster doses were administered past manufacturer expiration). On 06-Dec-2021, EXPIRED PRODUCT ADMINISTERED (12 or 13 expired booster doses were administered past manufacturer expiration) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported by the reporter. No treatment was reported by the reporter. Dose administered after 30 day use by date or after manufacturer date of expiry.   Reporter did not allow further contact
p/vax pt devel high fever & inj site redness, swelling & severe pain;
Started as mild sore throat then advanced next day into considerable sinus drainage that in turn resulted in significant coughing. Temperature normal days one, two and three then rose to 100.1. Tylenol two doses reduced and by day four temperature gone and other symptoms gone. If this was sinus infection or cold it is one of the strangest I have had in my 73 years.  Can only assume it was result of the Quad flu shot I received.
I21.4 ACUTE NON ST ELEVATION MI 4/26/2023 CAD (CORONARY ARTERY DISEASE) WO ANGINA J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 4/26/2023 CAD (CORONARY ARTERY DISEASE) WO ANGINA I21.4 ACUTE NON ST ELEVATION MI 4/26/2023 CAD (CORONARY ARTERY DISEASE) WO ANGINA J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 4/26/2023 CAD (CORONARY ARTERY DISEASE) WO ANGINA
Huge red welt (puffy) by next working day. 24 hrs after injection, red, raised, warm to touch, 3" around large "welt". Referred to PMD. 3 days later, resolved. No treatment applied.